A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Experts have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind ... The optic nerve helps transmit visual information from the eye's retina to the brain.

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and Wegovy ... responsible for transmitting visual information to the ...

On the one hand, we see the rise of weight-loss drugs like Ozempic, hailed as a revolutionary aid for those who can afford it. Conversely, the body positivity movement encourages self-acceptance ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

A comprehensive new study confirmed that GLP-1 medications such as Ozempic and Mounjaro have myriad ... other research that found GLP-1 medications aid in the treatment and prevention of Alzheimer ...